Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001256153-26-000002
Filing Date
2026-03-02
Accepted
2026-03-02 16:30:17
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 form4-03022026_040301.html 4  
1 form4-03022026_040301.xml 4 4001
  Complete submission text file 0001256153-26-000002.txt   5427
Mailing Address C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address
LEVIN JEREMY M (Reporting) CIK: 0001256153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 26708195

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)